Wedbush initiates coverage on Raptor Pharmaceuticals (NASDAQ: RPTP) with a Outperform rating and $7 price target.

The firm said ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE